Fibronectin Artificial Antibody Scaffold
Artificial Antibody Scaffold
Human fibronectin Type III (FN3) has epitope-binding loops analogous to those in naturally occurring immunoglobulins. This gives the resulting molecule the binding properties of an immunoglobulin antibody and the improved chemical and biological properties of the smaller (~100 amino acids) human FN3 molecule. Artificial antibody scaffolds are being employed as substitutes for antibodies in immunotherapeutics, immunotoxins and immunodiagnostics.
The ribbon model below shows the structural similarities between FN3 and the variable heavy (VH) chain of immunoglobulin.
Patents are issued in the United States and Australia; patent applications are pending in the United States, Europe, Canada and Japan.
Improved Fibronectin Type III Scaffolds for Artificial Antibody Polypeptides
An amino acid change in a non-loop region of the human fibronection Type III (FN3) molecule significantly increases its thermal and chemical stabilities.
In the engineering of artificial binding proteins, amino acid replacements, insertions and deletions (collectively referred to as mutations) are introduced to the FN3 scaffold. These mutations can possibly decrease the conformational stability of FN3. Because artifical binding proteins must maintain their three-dimensional structure to be functional, stability limits the number of mutations that can be introduced in the scaffold. The modification described in this technology increases the FN3 scaffold stability and allows more extensive mutations.
Patent applications are pending in the United States, Europe, Canada, Japan and Australia.
RCT licensed this technology exclusively in 2007.
Inventors
- Artificial Antibody Scaffold
- Shohei Koide, University of Rochester
- Improved Fibronectin Type III Scaffolds for Artificial Antibody Polypeptides
- Shohei Koide, University of Rochester
- bgh Polyadenylation Signal
- Blue Noise Mask
- Cisplatin and Carboplatin Anticancer Drugs
- Deimmunized Sarcin Ribotoxin
- Endotoxin-free ClearColi™ Expression System
- Fibronectin Artificial Antibody Scaffold
- Fullerenes
- Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)
- mRNA Transport Enhancer
- PEGylation: Non-Immunogenic Delivery of Protein-Based Drugs
- Pichia Classic Expression Platform
- Pichia GlycoSwitch® Protein Expression System
- Pichia Protein Expression System
- Prostate-Specific Antigen Blood Test for Prostate Cancer
- Shingles Vaccine Antigen
- Silver Sulfadiazine Burn Ointment
- Technetium-99M Complexes for Cardiac Imaging
- The CH2 Domain Scaffold – ABDURINS™
- Ultrasound Tissue Harmonic Imaging
- VIMPAT® (lacosamide) for Treatment of Epileptic Seizures
- Viral-mediated Gene Transfer System